Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by DELCOR ASSET CORP
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
007935
PHENERGAN
New Drug Application
Approval
New formulation
(S) Standard review drug
010926
PHENERGAN
New Drug Application
Approval
New formulation
(S) Standard review drug
011283
KENACORT
New Drug Application
Approval
New manufacturer
(S) Standard review drug
011600
KENALOG
New Drug Application
Approval
New formulation
(S) Standard review drug
011601
KENALOG
New Drug Application
Approval
New formulation
(S) Standard review drug
011602
KENALOG
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(S) Standard review drug
011689
PHENERGAN
New Drug Application
Approval
New manufacturer
(S) Standard review drug
012097
KENALOG IN ORABASE
New Drug Application
Approval
New formulation
(S) Standard review drug
012515
KENACORT
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018828
ZOVIRAX
New Drug Application
Approval
New formulation
(P) Priority review drug
020089
ZOVIRAX
New Drug Application
Approval
New formulation
(S) Standard review drug
020126
ZONALON
New Drug Application
Approval
New formulation
(S) Standard review drug
020934
LUXIQ
New Drug Application
Approval
New formulation
(S) Standard review drug
021026
VUSION
New Drug Application
Approval
New formulation
(S) Standard review drug
021142
OLUX
New Drug Application
Approval
New formulation
(S) Standard review drug
021738
EXTINA
New Drug Application
Approval
New formulation
(S) Standard review drug
050617
ERYGEL
New Drug Application
Approval
New formulation
(S) Standard review drug
050801
EVOCLIN
New Drug Application
Approval
New formulation
(S) Standard review drug
060571
MYCOSTATIN
Abbreviated New Drug Application
Approval
060572
MYCOLOG-II
Abbreviated New Drug Application
Approval
060574
MYCOSTATIN
Abbreviated New Drug Application
Approval
060575
MYCOSTATIN
Abbreviated New Drug Application
Approval
060576
MYCOLOG-II
Abbreviated New Drug Application
Approval
060577
MYCOSTATIN
Abbreviated New Drug Application
Approval
060578
MYCOSTATIN
Abbreviated New Drug Application
Approval
061533
MYCOSTATIN
Abbreviated New Drug Application
Approval
062606
MYCOLOG-II
Abbreviated New Drug Application
Approval
076243
LITHIUM CARBONATE
Abbreviated New Drug Application
Approval
078763
LITHIUM CARBONATE
Abbreviated New Drug Application
Approval
080292
PREDNISONE
Abbreviated New Drug Application
Approval
083677
PREDNISONE
Abbreviated New Drug Application
Approval
083943
KENALOG
Abbreviated New Drug Application
Approval
083944
KENALOG
Abbreviated New Drug Application
Approval
084343
KENALOG
Abbreviated New Drug Application
Approval
086240
KENALOG-H
Abbreviated New Drug Application
Approval
088832
PREDNISONE
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval